Transmucosal drug delivery is a novel route of drug administration which includes buccal, nasal, vaginal, and urethral cavities as route of drug delivery. Technological advancements and growing focus on research and development to analyze new delivery systems for medication in human have cemented the method for transmucosal drug delivery market in the recent times. Transmucosal drug delivery system offers various advantages over other routes of drug administration, making it a highly lucrative market for the companies involved in its value chain. One of the primary advantages of transmucosal drug delivery is it allows drugs to dodge the body’s natural defense mechanism. Many drugs, when administered by other delivery routes, may become ineffective due to high gastric acidity or first pass metabolism. As mucosal cavity, such as, nasal, vaginal, urethral, etc. has a permeable membrane that has a rich supply of blood vessels in the lining, drugs administered through these routes can be directly absorbed into the circulatory system and delivered at the target sites. Rise in trend of home health care is anticipated to drive the growth of the global transmucosal drug delivery market during the forecast period. Moreover, rapidly rising incidence of chronic disorders, including gastrointestinal, respiratory, and autoimmune disorders is anticipated to propel the global transmucosal drug delivery market in the near future.
Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53544
The global transmucosal drug delivery market can be classified on the basis of indication, route of administration, and region. On the basis of indication, the market can be divided into pain management, addiction treatment, hormonal therapies, and others. Based on route of administration, the market can be segmented into buccal, nasal, vaginal, and urethral. In terms of region, the global transmucosal drug delivery market can be categorized into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global transmucosal drug delivery market, followed by Europe, owing to high adoption of advanced treatment approaches and high prevalence of various chronic and acute disorders in the region. Furthermore, the region is home to several key players which boosts the transmucosal drug deliver market in the region. Favorable reimbursement landscape, aggressive awareness programs, better diagnostic measures, and presence of advanced therapy brands make North America a highly promising market for transmucosal drug delivery. Major pharmaceutical companies in Europe, such as, Roche and Novartis have a diverse and multicultural skill-based research scientists and experienced managers adept at recognizing the market value of new methods. This has led to the adoption of superior practices in drug safety and development of new therapies in the region. In Asia Pacific, the transmucosal drug delivery market is expected to grow at a significant rate due to the rapidly growing health care industry in major countries, such as, China, India, Japan, and Australia. Changing lifestyles and increasing urbanization in these countries have led to a gradual escalation in incidence of lifestyle diseases, such as, cancer, diabetes, and heart conditions. This has created multiple opportunities for the bio-pharmaceutical sector to expand, conduct research, and allocate substantial budget for the same. Moreover, the rapidly expanding pharmaceutical industry has attracted the focus of public and private organizations toward this market. Development of health care infrastructure, rise in population, boom in the biotechnology industry, and increase in the burden of diseases necessitating diagnostics are driving the growth of the transmucosal drug delivery market in Latin America. In addition, better distribution network and its proximity to the U.S. geographically are boosting the growth of the transmucosal drug delivery market in Latin America.
Request for Analysis of COVID19 Impact on Transmucosal Drug Delivery Market –
Major players operating in the global transmucosal drug delivery market include Cephalon, Inc., 3M Company, Antares Pharma, Inc., Teva Pharmaceuticals, West Therapeutic Development, LLC, Mylan, Inc., and BioDelivery Sciences International, Inc.
Pre book Market Report –
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
Ask for Discount :
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
Browse more Market Reports:
Substance Abuse Treatment Market:
Negative-pressure Wound Therapy (NPWT) Devices Market:
Respiratory Monitoring Devices Market:
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453